Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.
Related Posts
Russia shrugs off Trump’s threat of ‘very severe tariffs’
The Moscow Stock Exchange was up by 2.7% after it opened Tuesday morning.
NASA becomes latest federal agency to block China’s DeepSeek on ‘security and privacy concerns’
NASA is the latest federal agency to ban use of China’s DeepSeek AI technology by employees and block access to the platform, CNBC has learned.
OpenAI CEO Sam Altman denies sexual abuse allegations made by his sister in lawsuit
In a lawsuit filed in Missouri, Sam Altman’s sister has accused the OpenAI CEO of years of sexual abuse. Altman denied the claims.